News
Medpage Today on MSN1d
Do GLP-1 Drugs Pose a Risk to Lung Transplant Recipients?People taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation, a ...
After living with cystic fibrosis for over 20 years, Nicole Heller, of Norwalk, received a second chance at life through a ...
The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...
Researchers at the Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation ...
1don MSN
Molecular testing is transforming post-transplant care, reducing the need for invasive biopsies and personalizing medication ...
The likelihood for antibody-mediated rejection in lung transplant recipients was heightened with vs. without GLP-1 receptor ...
GOTHENBURG, SE / ACCESS Newswire / April 29, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - The 12-month ...
Advancements in heart transplant technology, focusing on machine perfusion's role in extending the time window for organ ...
Findings on tacrolimus use in lung transplant patients, showing its effectiveness over cyclosporine in preventing chronic ...
27 April 2025, Boston—Researchers at the Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation (ISHLT) marked the 10-year anniversary of modern ...
News-Medical.Net on MSN2d
HOPE technique shows promise for long-term donor lung preservationA study on donor lungs preserved outside the body before transplantation demonstrated that the hypothermic oxygenated machine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback